get_v1_kaspa_derivatives_diversity

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

No annotations are provided, so the description carries full burden. It only states the data is 'informational research data — not investment advice', but does not disclose if the tool is read-only, destructive, or any auth/rate-limit details.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is concise, front-loaded with core functionality, and includes helpful metadata (price, category). It is efficient with minimal waste.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no parameters and no output schema, the description should clarify the output format. It mentions 'breakdown' and 'distribution' but does not specify structure. Use cases help but completeness is moderate.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The input schema is empty with 0 parameters, so schema coverage is trivially 100%. The description adds no parameter details, but baseline for 0 parameters is 4.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly specifies 'Kaspa own-node peer-network breakdown (IPv4/IPv6) + user-agent distribution', which is a specific verb+resource. It distinguishes from siblings like 'get_v1_btc_derivatives_diversity' by asset (Kaspa).

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description mentions use cases ('network-health monitoring, node-operator analytics') but does not provide explicit when-to-use or when-not-to-use guidance, nor does it differentiate from other Kaspa health tools among siblings.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.